Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Bopindolol

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
Bopindolol
Clinical data
Trade namesSandonorm
Other namesLT 31-200
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
Drug classBeta blocker
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • (RS)-1-(tert-butylamino)-3-[(2-methyl-1H-indol-4-yl)oxy]propan-2-yl benzoate
CAS Number
PubChemCID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC23H28N2O3
Molar mass380.488 g·mol−1
3D model (JSmol)
  • CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C3=CC=CC=C3
  • InChI=1S/C23H28N2O3/c1-16-13-19-20(25-16)11-8-12-21(19)27-15-18(14-24-23(2,3)4)28-22(26)17-9-6-5-7-10-17/h5-13,18,24-25H,14-15H2,1-4H3 checkY
  • Key:UUOJIACWOAYWEZ-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Bopindolol (INNTooltip International Nonproprietary Name), sold under the brand nameSandonorm among others, is abeta blocker used to treathypertension.[1][2][3][4] It has been marketed in a number of countries throughout the world, for instance inEurope.[2]

Pharmacology

[edit]

Bopindolol is anesterprodrug ofmepindolol.[3][4] It acts as anon-selective or dualβ1- andβ2-adrenergic receptorantagonist.[4] Bopindolol hasintrinsic sympathomimetic activity (ISA) andmembrane-stabilizing activity (MSA).[4] Besides the β1- and β2-adrenergic receptors, bopindolol shows very lowaffinity for theβ3-adrenergic receptor and interacts with certainserotonin receptors such as theserotonin5-HT1A receptor with strong affinity.[4]

Chemistry

[edit]

The predictedlog P of bopindolol ranges from 4.45 to 4.7.[5][6] It showed the highest predictedlipophilicity of 30 clinically relevant beta blockers, with the second most lipophilic beta blocker predicted to be the better-knownpenbutolol.[7]

Synthesis

[edit]

The reaction of 4-Hydroxy-2-methylindole [35320-67-3] (1) with epichlorohydrin in the presence of lye led to 2-methyl-4-(oxiran-2-ylmethoxy)-1H-indole [62119-47-5] (2). Addition of tert-butylamine led to 4-(2-Hydroxy-3-tert-butylaminopropoxy)-2-methylindole [23869-98-9] (3). Ester formation with benzoic anhydride [93-97-0] (4) in the presence of hexamethylphosphoric acid triamide [680-31-9] completed the synthesis of Bopindolol (5).

Thieme Patent:[8] Starting amnine:[9]

History

[edit]

Bopindolol is related to and was developed as a successor topindolol.[4] It was first described in the literature by at least 1977.[1]

References

[edit]
  1. ^abElks J (2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 169.ISBN 978-1-4757-2085-3. Retrieved10 July 2025.
  2. ^abApotheker-Verein S (2004).Index Nominum: International Drug Directory. Index Nominum: International Drug Directory. Medpharm Scientific Publishers. p. 154.ISBN 978-3-88763-101-7. Retrieved10 July 2025.
  3. ^abMorton I, Hall J (2012).Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Netherlands. p. 53.ISBN 978-94-011-4439-1. Retrieved10 July 2025.
  4. ^abcdefNagatomo T, Hosohata Y, Ohnuki T, Nakamura T, Hattori K, Suzuki J, et al. (Spring 2001)."Bopindolol: pharmacological basis and clinical implications".Cardiovascular Drug Reviews.19 (1):9–24.doi:10.1111/j.1527-3466.2001.tb00180.x.PMID 11314603.
  5. ^"Bopindolol".PubChem. U.S. National Library of Medicine. Retrieved10 July 2025.
  6. ^"Bopindolol: Uses, Interactions, Mechanism of Action".DrugBank Online. 20 October 2010. Retrieved10 July 2025.
  7. ^Mannhold R (February 2005). "The impact of lipophilicity in drug research: a case report on beta-blockers".Mini Reviews in Medicinal Chemistry.5 (2):197–205.doi:10.2174/1389557053402701.PMID 15720289.
  8. ^DE2635209 idem Franz Troxler, Fritz Seemann,U.S. patent 4,434,176 (1984 to Sandoz Ltd.).
  9. ^Franz Dr Troxler & Albert Dr Hofmann, CH453363 (1968 to Sandoz AG).


β, non-selective
β1-selective
β2-selective
α1- + β-selective
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
Retrieved from "https://en.wikipedia.org/w/index.php?title=Bopindolol&oldid=1300260857"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp